Vasopressors & The Older Patient - The 65 Trial

April 27, 2020 00:22:04
Vasopressors & The Older Patient - The 65 Trial
Critical Care Perspectives in Emergency Medicine
Vasopressors & The Older Patient - The 65 Trial

Apr 27 2020 | 00:22:04

/

Show Notes

Current guidelines for many critical illnesses recommend targeting a MAP of 65 mm Hg, with consideration of higher MAPs in older patients with chronic HTN. Recent literature, however, suggests increased mortality in older patients who are exposed to larger quantities of vasopressor medications.  In this podcast, we do a deep dive into the recently published 65 Trial, which sought to evaluate the effect of permissive hypotension in older patients with vasodilatory hypotension.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

November 23, 2020 00:41:34
Episode Cover

2020 AHA Guidelines for Cardiopulmonary Resuscitation

Approximately 350,000 adults in the US experience an out-of-hospital cardiac arrest (OHCA).  Despite numerous potential improvements in treatments, survival from OHCA remains essentially unchanged...

Listen

Episode 0

June 19, 2017 00:17:50
Episode Cover

Angiotensin II for Vasodilatory Shock?

This month Mike McCurdy rejoins the podcast to discuss the ATHOS-3 trial.  Mike was one of the co-authors on this impressive publication and gives...

Listen

Episode 0

August 05, 2021 00:23:56
Episode Cover

Pigtail Catheters for Traumatic Hemothorax?

Traumatic hemothorax has traditionally been treated with a large bore thoracostomy to prevent retained hemothorax and morbidity.  In this podcast we discuss the results...

Listen